Page last updated: 2024-10-30

metformin and Toxocariasis

metformin has been researched along with Toxocariasis in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Toxocariasis: Infection by round worms of the genus TOXOCARA, usually found in wild and domesticated cats and dogs and foxes, except for the larvae, which may produce visceral and ocular larva migrans in man.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Salama, AM1
Elmahy, RA1
Ibrahim, HA1
Amer, AIM1
Eltantawy, AF1
Elgendy, DI1

Other Studies

1 other study available for metformin and Toxocariasis

ArticleYear
Effects of metformin on parasitological, pathological changes in the brain and liver and immunological aspects during visceral toxocariasis in mice.
    Parasitology research, 2023, Volume: 122, Issue:12

    Topics: Albendazole; Animals; Brain; Liver; Metformin; Mice; Toxocara canis; Toxocariasis

2023